Controlled Clinical Trial
doi: 10.1212/01.wnl.0000249310.25427.f2.
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia
Affiliations
- PMID: 17190951
- DOI: 10.1212/01.wnl.0000249310.25427.f2
Item in Clipboard
Controlled Clinical Trial
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia
Neurology.
.
Abstract
We compared the responsiveness of the Cervical Dystonia Impact Profile (CDIP-58), Medical Outcome Study Short Form-Health Survey (SF-36), Functional Disability Questionnaire (FDQ), and Pain and Activities of Daily Living subscales of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in participants with cervical dystonia treated with botulinum toxin A. Subscales of CDIP-58 were more sensitive in detecting statistical and clinical change than comparable subscales of the SF-36, FDQ, and TWSTRS.
Similar articles
-
Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.Funct Neurol. 2007 Apr-Jun;22(2):95-100. Funct Neurol. 2007. PMID: 17637212
-
Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.Mov Disord. 1997 Jan;12(1):100-2. doi: 10.1002/mds.870120117. Mov Disord. 1997. PMID: 8990061
-
A pilot study of botulinum toxin A for headache in cervical dystonia.Headache. 2005 Sep;45(8):1073-7. doi: 10.1111/j.1526-4610.2005.05190.x. Headache. 2005. PMID: 16109123 Clinical Trial.
-
The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Aug;104(2):e1-11. doi: 10.1016/j.tripleo.2007.02.004. Epub 2007 Jun 7. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007. PMID: 17560141 Review.
-
Natural history of posttraumatic cervical dystonia.Mov Disord. 2004 Dec;19(12):1492-8. doi: 10.1002/mds.20239. Mov Disord. 2004. PMID: 15390063 Review.
Cited by
-
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE).BMC Neurol. 2011 Nov 4;11:140. doi: 10.1186/1471-2377-11-140. BMC Neurol. 2011. PMID: 22054223 Free PMC article.
-
Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.J Neural Transm (Vienna). 2013 Mar;120(3):487-96. doi: 10.1007/s00702-012-0887-7. Epub 2012 Aug 17. J Neural Transm (Vienna). 2013. PMID: 22899277 Free PMC article. Review.
-
Trust the Patient Not the Doctor: The Determinants of Quality of Life in Cervical Dystonia.Front Neurol. 2020 Sep 4;11:991. doi: 10.3389/fneur.2020.00991. eCollection 2020. Front Neurol. 2020. PMID: 33013654 Free PMC article.
-
Improvement in Quality of Life with OnabotulinumtoxinA for Cervical Dystonia: POSTURe.Can J Neurol Sci. 2021 Sep;48(5):676-684. doi: 10.1017/cjn.2020.275. Epub 2020 Dec 21. Can J Neurol Sci. 2021. PMID: 33342445 Free PMC article.
-
The non-motor syndrome of primary dystonia: clinical and pathophysiological implications.Brain. 2012 Jun;135(Pt 6):1668-81. doi: 10.1093/brain/awr224. Epub 2011 Sep 20. Brain. 2012. PMID: 21933808 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
